3
Announcements
Trials
Browse
Landscape
Status
Completed
5
Active not recruiting
4
Unknown
1
Terminated
1
Suspended
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Neoplasm Metastasis
25
Leukemia, Myeloid, Acute
25
Breast Neoplasms
19
Prostatic Neoplasms
16
Myelodysplastic Syndromes
15
Lymphoma, Large B-Cell, Diffuse
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Multiple Myeloma
14
Lung Neoplasms
13
Colorectal Neoplasms
12
Carcinoma, Non-Small-Cell Lung
12
Triple Negative Breast Neoplasms
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Pancreatic Neoplasms
11
Burkitt Lymphoma
11
Neoplasms
9
Lymphoma, Mantle-Cell
9
Leukemia, Myelomonocytic, Chronic
9
Ovarian Neoplasms
8
Melanoma
8
Lymphoma, T-Cell
8
Stomach Neoplasms
7
Carcinoma, Renal Cell
7
Squamous Cell Carcinoma of Head and Neck
6
Lymphoma, B-Cell
6
Myeloproliferative Disorders
5
Mouth Neoplasms
5
Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Fallopian Tube Neoplasms
5
Interventions
pembrolizumab
20
Gemcitabine
18
Cisplatin
14
Magnetic Resonance Spectroscopy
13
enfortumab vedotin
12
Specimen Handling
10
Cystectomy
10
Docetaxel
8
Mitomycin
7
Standard of Care
6
Cystoscopy
6
Transurethral Resection of Bladder
5
Radiotherapy
5
Carboplatin
5
durvalumab
4
Practice Guidelines as Topic
4
Nivolumab
4
Radiation
3
Multiparametric Magnetic Resonance Imaging
3
Mitozytrex
3
Fluorouracil
3
tislelizumab
2
dehydroftorafur
2
cemiplimab
2
avelumab
2
alvimopan
2
Therapeutics
2
Surveys and Questionnaires
2
Surgical Procedures, Operative
2
Radiosurgery
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Urinary Bladder Neoplasms
×
Biopsy
×
Clear all
NCT07327489
2026-01-08
ELEPHAS-05
Elephas
Recruiting
2,000 enrolled